KR100447096B1 - 바이러스성또는세균성뉴라미니다제의신규한선택적저해제 - Google Patents

바이러스성또는세균성뉴라미니다제의신규한선택적저해제 Download PDF

Info

Publication number
KR100447096B1
KR100447096B1 KR1019970705932A KR19970705932A KR100447096B1 KR 100447096 B1 KR100447096 B1 KR 100447096B1 KR 1019970705932 A KR1019970705932 A KR 1019970705932A KR 19970705932 A KR19970705932 A KR 19970705932A KR 100447096 B1 KR100447096 B1 KR 100447096B1
Authority
KR
South Korea
Prior art keywords
compound
group
independently
groups
carbon atoms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
KR1019970705932A
Other languages
English (en)
Korean (ko)
Other versions
KR19980703600A (ko
Inventor
노르베르트 베. 비스코프베르거
초웅 유. 킴
윌라드 류
홍타오 리우
매튜 에이. 윌리엄스
Original Assignee
갈리드사이언스인코오퍼레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27410155&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR100447096(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/476,946 external-priority patent/US5866601A/en
Application filed by 갈리드사이언스인코오퍼레이티드 filed Critical 갈리드사이언스인코오퍼레이티드
Publication of KR19980703600A publication Critical patent/KR19980703600A/ko
Application granted granted Critical
Publication of KR100447096B1 publication Critical patent/KR100447096B1/ko
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Epoxy Compounds (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
KR1019970705932A 1995-02-27 1996-02-26 바이러스성또는세균성뉴라미니다제의신규한선택적저해제 Expired - Lifetime KR100447096B1 (ko)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US39524595A 1995-02-27 1995-02-27
US8/395,245 1995-02-27
US08/395,245 1995-02-27
US8/476,946 1995-06-06
US08/476,946 1995-06-06
US08/476,946 US5866601A (en) 1995-02-27 1995-06-06 Carbocyclic compounds
US58056795A 1995-12-29 1995-12-29
US8/580,567 1995-12-29
US08/580.567 1995-12-29

Publications (2)

Publication Number Publication Date
KR19980703600A KR19980703600A (ko) 1998-12-05
KR100447096B1 true KR100447096B1 (ko) 2005-10-11

Family

ID=27410155

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019970705932A Expired - Lifetime KR100447096B1 (ko) 1995-02-27 1996-02-26 바이러스성또는세균성뉴라미니다제의신규한선택적저해제

Country Status (26)

Country Link
US (3) US5952375A (https=)
EP (1) EP0759917B1 (https=)
JP (3) JP3300365B2 (https=)
KR (1) KR100447096B1 (https=)
CN (2) CN1185223C (https=)
AT (2) ATE191711T1 (https=)
AU (1) AU720933B2 (https=)
BR (2) BR9607098B8 (https=)
CZ (1) CZ297945B6 (https=)
DE (4) DE69607704T2 (https=)
DK (1) DK0759917T3 (https=)
ES (2) ES2249863T3 (https=)
GR (1) GR3033914T3 (https=)
HU (1) HU228450B1 (https=)
LU (1) LU90991I2 (https=)
MX (1) MX9706496A (https=)
NL (1) NL300105I2 (https=)
NO (1) NO318455B1 (https=)
NZ (1) NZ306625A (https=)
PL (1) PL194173B1 (https=)
PT (1) PT759917E (https=)
RU (1) RU2181357C2 (https=)
SG (1) SG45864A1 (https=)
SI (1) SI9620042A (https=)
UA (1) UA56128C2 (https=)
WO (1) WO1996026933A1 (https=)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100819759B1 (ko) 2005-12-01 2008-04-07 (주)파인켐 아자이드 화합물의 폭발성을 제거한 공정을 이용한 1,2-다이아미노 화합물 또는 이의 부가염 제조 방법
KR20200106607A (ko) 2019-03-05 2020-09-15 주식회사 코아팜바이오 오셀타미비르 함유 의약 조성물

Families Citing this family (85)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9607098B8 (pt) 1995-02-27 2014-11-18 Gilead Sciences Inc Composto e composição farmacêutica.
US5714509A (en) * 1995-05-03 1998-02-03 The University Of Alabama Inhibitors of bacterial sialidase and methods of making and using the same
US5763483A (en) * 1995-12-29 1998-06-09 Gilead Sciences, Inc. Carbocyclic compounds
US6093816A (en) 1996-06-27 2000-07-25 Isis Pharmaceuticals, Inc. Cationic lipids
US5859284A (en) 1996-08-23 1999-01-12 Gilead Sciences, Inc. Preparation of carbocyclic compounds
US6518438B2 (en) 1996-08-23 2003-02-11 Gilead Sciences, Inc. Preparation of cyclohexene carboxylate derivatives
DE69711395T2 (de) * 1996-08-23 2002-11-07 Gilead Sciences, Inc. Verfahren zur herstellung von cyclohexen-carboxylatderivate
US5994377A (en) * 1996-10-21 1999-11-30 Gilead Sciences, Inc. Piperidine compounds
CA2268756A1 (en) * 1996-10-21 1998-04-30 Gilead Sciences, Inc. Piperidine compounds
NZ335368A (en) * 1996-11-14 2001-08-31 Biota Scient Management Macromolecular compound with one or more neuraminidase binders, binds to the active site of influenza virus neuraminidase
AU8673598A (en) * 1997-08-01 1999-02-22 University Of Florida Neuraminidase inhibitors
US5886213A (en) * 1997-08-22 1999-03-23 Gilead Sciences, Inc. Preparation of carbocyclic compounds
NZ502988A (en) * 1997-09-17 2002-08-28 Gilead Sciences Inc 5-Acetamido-4-amino-2-propionyloxy-6-isopropoxy-1-cyclohexene useful for treating influenza
US20040053999A1 (en) * 1997-09-17 2004-03-18 Bischofberger Norbert W. Novel compounds and methods for synthesis and therapy
TW477783B (en) * 1997-12-12 2002-03-01 Gilead Sciences Inc Novel compounds useful as neuraminidase inhibitors and pharmaceutical compositions containing same
CA2315262C (en) * 1997-12-17 2009-11-10 Biocryst Pharmaceuticals, Inc. Substituted cyclopentane and cyclopentene compounds useful as neuraminidase inhibitors
EP1315698A1 (en) * 1998-04-23 2003-06-04 Abbott Laboratories Pyrrolidines as inhibitors of neuraminidases
US6455571B1 (en) 1998-04-23 2002-09-24 Abbott Laboratories Inhibitors of neuraminidases
US6518305B1 (en) 1998-04-23 2003-02-11 Abbott Laboratories Five-membered carbocyclic and heterocyclic inhibitors of neuraminidases
DE69900483T2 (de) * 1998-05-13 2002-06-27 F. Hoffmann-La Roche Ag, Basel Verfahren zur Herstellung von Shikiminsäure und deren Derivate
WO2000029385A1 (en) * 1998-11-13 2000-05-25 Gilead Sciences, Inc. 1,4,5,6-tetrahydro-pyridazine derivatives, their preparation and their use as neuraminidase inhibitors
AUPP913999A0 (en) * 1999-03-12 1999-04-01 Biota Scientific Management Pty Ltd Novel chemical compounds and their use
ES2198244T3 (es) * 1999-06-11 2004-02-01 F. Hoffmann-La Roche Ag Procedimiento para la preparacion de inhibidor ro-64-0796 de la neuraminidasa.
DE19930177B4 (de) 1999-06-30 2007-02-08 Nikolai Vladimirovich Bovin Intermolekular assoziierende Verbindungen und deren Verwendung
US6593314B1 (en) 1999-10-19 2003-07-15 Abbott Laboratories Neuraminidase inhibitors
BR0010525A (pt) * 1999-10-19 2002-11-26 Abbott Lab cido 1-ciclo-hexeno-1-carboxìlico e 1-ciclo-hexeno-1carboxilatos como inibidores de neuraminidase
US6627396B1 (en) * 1999-10-28 2003-09-30 The Regents Of The University Of California Influenza sensor
JP2001131144A (ja) 1999-11-02 2001-05-15 Sagami Chem Res Center ７−アザビシクロ［４．１．０］ヘプト−３−エン−３−カルボン酸エステル類の製造方法
US6462226B1 (en) 1999-12-03 2002-10-08 Hoffmann-La Roche Inc. Process for the preparation of 4,5-diamino shikimic acid derivatives
EP1486499A1 (en) 1999-12-27 2004-12-15 Sagami Chemical Research Center Endo-2,3-epoxy-7-oxabicylco[2.2.1]heptane-endo-5-carboxylic acid derivative
US8642051B2 (en) * 2000-03-21 2014-02-04 Suzanne Jaffe Stillman Method of hydration; infusion packet system(s), support member(s), delivery system(s), and method(s); with business model(s) and Method(s)
AU2001252578A1 (en) * 2000-04-25 2001-11-07 Sankyo Company Limited Preventives for influenza
GB0015324D0 (en) * 2000-06-22 2000-08-16 Biota Scient Management Medicaments
AU2001281846B2 (en) 2000-06-27 2006-04-27 Cheplapharm Arzneimittel Gmbh Method for preparing a composition
AUPR001000A0 (en) 2000-09-08 2000-10-05 Biota Scientific Management Pty Ltd Novel chemical compounds and their use
WO2002092555A1 (en) * 2001-05-11 2002-11-21 Sankyo Company, Limited Sialic acid derivatives
US6964784B2 (en) 2002-03-07 2005-11-15 Optigenex, Inc. Method of preparation and composition of a water soluble extract of the bioactive component of the plant species uncaria for enhancing immune, anti-inflammatory, anti-tumor and dna repair processes of warm blooded animals
RU2220739C1 (ru) * 2002-08-30 2004-01-10 Гапонюк Петр Яковлевич Интраназальное средство
US7807174B2 (en) * 2002-11-22 2010-10-05 Nexbio, Inc. Class of therapeutic protein based molecules
US7122684B2 (en) 2003-03-13 2006-10-17 Roche Colorado Corporation Process for preparing 1,2-diamino compounds
DE602004031115D1 (de) 2003-06-16 2011-03-03 Acad Of Science Czech Republic Pyrimidinverbindungen mit phosphonatgruppen als antivirale nucleotidanaloga
WO2007053792A2 (en) * 2005-11-05 2007-05-10 Amplyx Pharmaceuticals, Inc. Improving the pharmacokinetics of protease inhibitors and other drugs
US7687658B2 (en) 2005-11-25 2010-03-30 Hetero Drugs Limited Process for oseltamivir phosphate
EP2178819A2 (en) 2005-12-28 2010-04-28 F.Hoffmann-La Roche Ag Epoxide intermediate in the tamiflu synthesis
AU2007218733B2 (en) 2006-02-20 2012-11-15 Chugai Seiyaku Kabushiki Kaisha Pharmaceutical composition comprising oseltamivir phosphate
US20080063722A1 (en) * 2006-09-08 2008-03-13 Advanced Inhalation Research, Inc. Composition of a Spray-Dried Powder for Pulmonary Delivery of a Long Acting Neuraminidase Inhibitor (LANI)
US20080306098A1 (en) * 2006-11-06 2008-12-11 Mutz Mitchell W Pharmacokinetics of protease inhibitors and other drugs
US8227425B2 (en) 2007-01-23 2012-07-24 Therapicon Srl Antiviral compounds
US20080194801A1 (en) * 2007-02-14 2008-08-14 Swanson Basil I Robust multidentate ligands for diagnosis and anti-viral drugs for influenza and related viruses
US8435769B2 (en) 2007-04-13 2013-05-07 Monsanto Technology Llc Use of glyphosate to produce shikimic acid in microorganisms
US20090054334A1 (en) * 2007-05-23 2009-02-26 Mutz Mitchell W Combinatorial improvement of bifunctional drug properties
JP5509080B2 (ja) * 2007-08-31 2014-06-04 アカデミア シニカ 抗インフルエンザ活性を有するオセルタミビル含有ホスホネートコンジナーの合成
EP2201123B1 (en) 2007-10-16 2012-01-18 Monsanto Technology, LLC Processes for recovering shikimic acid
WO2009055042A1 (en) * 2007-10-24 2009-04-30 Amplyx Pharmaceuticals, Inc. Enhancing the efficacy of anti-infective therapeutics
US8304553B2 (en) * 2007-12-19 2012-11-06 Nanyang Technological University Method of forming oseltamivir and derivatives thereof
US8334319B2 (en) * 2008-01-04 2012-12-18 Roche Palo Alto Llc Polymorphic forms of oseltamivir phosphate
US20100081713A1 (en) * 2008-03-19 2010-04-01 CombinatoRx, (Singapore) Pte. Ltd. Compositions and methods for treating viral infections
US20120058937A9 (en) 2008-04-15 2012-03-08 Tsrl, Inc. Prodrugs of Neuraminidase Inhibitors
TWI491416B (zh) 2008-12-24 2015-07-11 Daiichi Sankyo Co Ltd 吸入用乾燥粉末醫藥組成物
CN101486664B (zh) * 2008-12-31 2013-09-04 北京大学深圳研究生院 用作流感病毒神经氨酸酶抑制剂的多取代五元环小分子化合物
EA201101564A1 (ru) 2009-05-15 2012-07-30 Редкс Фарма Лимитед Редокс производные лекарственных средств
WO2011021223A2 (en) * 2009-08-19 2011-02-24 Msn Laboratories Limited Novel salts of ethyl (3r, 4s, 5r)-4,5-imino-3-(l-ethylpropoxy)-1- cvclohexene-1-carboxylate and its use
JP5837502B2 (ja) * 2009-11-11 2015-12-24 スリーエム イノベイティブ プロパティズ カンパニー ポリマー組成物並びにその製造方法及び物品
IT1396620B1 (it) 2009-11-25 2012-12-14 Therapicon Srl Analoghi chimerici
EA201300142A1 (ru) 2010-07-16 2013-08-30 Гриндекс, Джоинт Сток Кампани Производные 1,4-дигидропиридина, обладающие противовирусной эффективностью
AT510585B1 (de) 2010-11-18 2012-05-15 Apeptico Forschung & Entwicklung Gmbh Zusammensetzung umfassend ein peptid und ein hemmstoff der viralen neuraminidase
KR101369584B1 (ko) 2011-04-19 2014-03-06 일양약품주식회사 페닐-이속사졸 유도체 및 그의 제조방법
EP2578218A1 (en) 2011-10-06 2013-04-10 Grindeks, A Joint Stock Company Antiviral efficacy of disodium 2,6-dimethyl-1,4-dihydropyridine-3,5-bis(carbonyloxyacetate) and its derivatives
DE102011117128A1 (de) 2011-10-28 2013-05-02 Christian-Albrechts-Universität Zu Kiel Verbindungen zur Therapie der Influenza
RU2469020C1 (ru) * 2011-11-08 2012-12-10 Александр Васильевич Иващенко (3r,4r,5s)-5-амино-4-ациламино-3-(1-этил-пропокси)-циклогекс-1-ен-карбоновые кислоты, их эфиры и способ применения
RU2489422C1 (ru) * 2012-05-12 2013-08-10 Александр Васильевич Иващенко Фторзамещенные (3r,4r,5s)-5-гуанидино-4-ациламино-3-(пентан-3-илокси)циклогексен-1-карбоновые кислоты, их эфиры и способ применения
RU2521593C1 (ru) * 2013-02-27 2014-06-27 Общество с ограниченной ответственностью "Интеллектуальный Диалог" Моно и дифторзамещенные этил (3r,4r,5s)-5-азидо-4-ацетиламино-3-(1-этилпропокси)-циклогексен-1-карбоксилаты, способ получения и применения
JP6453050B2 (ja) * 2013-11-15 2019-01-16 国立大学法人富山大学 ２−デオキシ−２，３−ジデヒドロシアル酸誘導体およびその製造法
CN103819357B (zh) * 2014-01-28 2016-03-16 浙江大学 (-)-有效霉醇叠氮四乙酸酯的制备方法
KR20160124764A (ko) 2014-02-14 2016-10-28 도아 에이요 가부시키가이샤 고리형 탄화수소 화합물
US20170100385A1 (en) 2014-05-12 2017-04-13 Glaxosmithkline Intellectual Property (No. 2) Limited Pharmaceutical compositions comprising danirixin for treating infectious diseases
US9392814B2 (en) 2014-06-06 2016-07-19 Nicholas J. Singer Delivery system for drinks
GB2532178A (en) * 2014-06-09 2016-05-18 Redx Pharma Plc Antiviral compounds
DK3236972T3 (en) 2014-12-26 2021-10-04 Univ Emory Antivirale N4-hydroxycytidin-derivativer
USD773313S1 (en) 2015-06-23 2016-12-06 Nicholas J. Singer Package
US10676428B2 (en) 2015-12-17 2020-06-09 Ramot At Tel-Aviv University Ltd. Antiviral agents for amantadine-resistant influenza A
KR102339817B1 (ko) 2016-06-30 2021-12-16 한미약품 주식회사 오셀타미비어 함유 경구용 고형제제 및 그 제조방법
RU2727962C1 (ru) * 2016-08-10 2020-07-28 Сионоги Энд Ко., Лтд. Фармацевтические композиции, содержащие замещенные полициклические пиридоновые производные и их пролекарство
JP6804790B1 (ja) 2017-12-07 2020-12-23 エモリー ユニバーシティー Ｎ４−ヒドロキシシチジンおよび誘導体ならびにそれらに関連する抗ウイルス用途
WO2025221915A1 (en) * 2024-04-16 2025-10-23 University Of Utah Research Foundation Synthesis of gadusol and related compounds

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4968788A (en) * 1986-04-04 1990-11-06 Board Of Regents, The University Of Texas System Biologically reversible phosphate and phosphonate protective gruops
US5206400A (en) * 1986-07-07 1993-04-27 Ohio State University Diastereomeric mono- and di-substituted diamino cyclohexane compounds and the method of preparation thereof
DE68926743T2 (de) * 1988-01-12 1997-01-09 Univ Texas Die freisetzung des histamin hemmenden faktors sowie diesen enthaltende präparate
US5175273A (en) * 1988-07-01 1992-12-29 Genentech, Inc. Nucleic acid intercalating agents
US5270340A (en) * 1988-12-27 1993-12-14 Bayer Aktiengesellschaft Substituted 2-cyclohexen-1-yl-amine fungicidal and herbicidal agents
GB2238049A (en) * 1989-11-22 1991-05-22 Ki Nii Epidemiologii I Infekts Method for preparing inhibitor for influenza virus neuraminidase
CZ288492B6 (en) * 1990-04-24 2001-06-13 Biota Scient Management Derivatives of alpha-D-neuraminic acid, process of their preparation, their use and pharmaceutical preparations based thereon
WO1992006691A1 (en) * 1990-10-19 1992-04-30 Biota Scientific Management Pty. Ltd. Anti-viral compounds that bind the active site of influenza neuramidase and display in vivo activity against orthomyxovirus and paramyxovirus
DE4033415A1 (de) * 1990-10-20 1992-04-23 Bayer Ag Antimikrobielle mittel sowie substituierte 2-cyclohexan-1-yl-amin-derivate und deren herstellung
DE4131311A1 (de) * 1991-09-20 1993-04-01 Basf Ag Dihydropyranderivate und diese enthaltende pflanzenschutzmittel
CA2081068C (en) * 1991-10-23 2005-11-29 Laurence Mark Von Itzstein Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of .alpha.-d-neuraminic acid
GB9126725D0 (en) * 1991-12-17 1992-02-12 Glaxo Group Ltd Process
FR2687674B1 (fr) * 1992-02-07 1995-05-19 Roussel Uclaf Nouveaux derives de la pyridone, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant.
US5292938A (en) * 1992-04-13 1994-03-08 Associated Universities, Inc. Synthesis of 4-substituted-trans-1, 2-diaminocyclohexyl polyaminocarboxylate metal chelating agents for the preparation of stable radiometal antibody immunoconjugates for therapy and spect and pet imaging
US5633360A (en) 1992-04-14 1997-05-27 Gilead Sciences, Inc. Oligonucleotide analogs capable of passive cell membrane permeation
GB9220327D0 (en) * 1992-09-25 1992-11-11 Glaxo Group Ltd Process
GB9220241D0 (en) * 1992-09-25 1992-11-11 Glaxo Group Ltd Process
US5639786A (en) * 1992-12-04 1997-06-17 Biota Scientific Management, Pty., Ltd. Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of α-D-neuraninic acid
US5514798A (en) * 1993-06-02 1996-05-07 Gilead Sciences, Inc. Method and cyclic carbonates for nucleotide analogues
US5819730A (en) * 1993-06-09 1998-10-13 Glaxo Wellcome Australia Ltd. Device for administering pharmaceutical substances
GB9311873D0 (en) * 1993-06-09 1993-07-28 Glaxo Group Ltd Process
GB9312531D0 (en) * 1993-06-17 1993-08-04 Glaxo Group Ltd Process
GB9325841D0 (en) * 1993-12-17 1994-02-23 Glaxo Group Ltd Chemical compounds
GB9400206D0 (en) * 1994-01-07 1994-03-02 Glaxo Group Ltd Chemical compound
AUPM354694A0 (en) * 1994-01-27 1994-02-17 Biota Scientific Management Pty Ltd Chemical compounds
US5985859A (en) * 1994-04-14 1999-11-16 The University Of Alabama Methods of inhibiting bacterial sialidase
GB9410817D0 (en) * 1994-05-28 1994-07-20 Glaxo Group Ltd Medicaments
AUPM725794A0 (en) * 1994-08-03 1994-08-25 Biota Scientific Management Pty Ltd Chemical compounds
US5556963A (en) * 1994-08-05 1996-09-17 Oklahoma Medical Research Foundation Synthesis of 4-alkoxy-N-acetylneuraminic acid
GB9416365D0 (en) * 1994-08-12 1994-10-05 Glaxo Group Ltd Medicaments
US5512596A (en) * 1994-09-02 1996-04-30 Gilead Sciences, Inc. Aromatic compounds
WO1996014314A2 (en) 1994-11-04 1996-05-17 Gilead Sciences, Inc. Thiepane compounds inhibiting and detecting hiv protease
US5866601A (en) * 1995-02-27 1999-02-02 Gilead Sciences, Inc. Carbocyclic compounds
BR9607098B8 (pt) * 1995-02-27 2014-11-18 Gilead Sciences Inc Composto e composição farmacêutica.
US5602277A (en) 1995-03-30 1997-02-11 Biocryst Pharmaceuticals, Inc. Substituted benzene derivatives useful as neuraminidase inhibitors
US5714509A (en) * 1995-05-03 1998-02-03 The University Of Alabama Inhibitors of bacterial sialidase and methods of making and using the same
GB9510141D0 (en) 1995-05-19 1995-07-12 Biota Scient Management Chemical compounds
GB9525389D0 (en) 1995-12-12 1996-02-14 Biota Scient Management Ltd Chemical compounds
HUP9801766A3 (en) * 1995-05-19 2000-09-28 Biota Scient Managemant Pty Lt 6-carboxamido dihydropyran derivatives, process for producing them and medicaments containing the same
GB9516276D0 (en) * 1995-08-08 1995-10-11 Biota Scient Management Chemical compounds
US5763483A (en) * 1995-12-29 1998-06-09 Gilead Sciences, Inc. Carbocyclic compounds
DE69711395T2 (de) 1996-08-23 2002-11-07 Gilead Sciences, Inc. Verfahren zur herstellung von cyclohexen-carboxylatderivate
US5859284A (en) 1996-08-23 1999-01-12 Gilead Sciences, Inc. Preparation of carbocyclic compounds
US5948816A (en) * 1996-09-10 1999-09-07 Daikin Industries, Ltd. 4-substituted-2,7-dideoxy-7-fluoro-2,3-didehydro-sialic acid compounds
US5886213A (en) 1997-08-22 1999-03-23 Gilead Sciences, Inc. Preparation of carbocyclic compounds

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100819759B1 (ko) 2005-12-01 2008-04-07 (주)파인켐 아자이드 화합물의 폭발성을 제거한 공정을 이용한 1,2-다이아미노 화합물 또는 이의 부가염 제조 방법
KR20200106607A (ko) 2019-03-05 2020-09-15 주식회사 코아팜바이오 오셀타미비르 함유 의약 조성물
KR20240158209A (ko) 2019-03-05 2024-11-04 주식회사 코아팜바이오 오셀타미비르 함유 의약 조성물
KR20260020456A (ko) 2019-03-05 2026-02-11 주식회사 코아팜바이오 오셀타미비르 함유 의약 조성물

Also Published As

Publication number Publication date
GR3033914T3 (en) 2000-11-30
AU5357196A (en) 1996-09-18
PL322000A1 (en) 1998-01-05
DE69635231D1 (de) 2006-02-09
WO1996026933A1 (en) 1996-09-06
DE69607704D1 (de) 2000-05-18
BR9607098A (pt) 1997-11-04
DE69635231T2 (de) 2006-07-13
CN100409844C (zh) 2008-08-13
PT759917E (pt) 2000-10-31
HUP9800026A2 (hu) 1999-09-28
HU228450B1 (en) 2013-03-28
LU90991I2 (fr) 2003-02-11
KR19980703600A (ko) 1998-12-05
RU2181357C2 (ru) 2002-04-20
PL194173B1 (pl) 2007-05-31
DE759917T1 (de) 1998-10-22
DK0759917T3 (da) 2000-07-31
NO318455B1 (no) 2005-03-21
US6225341B1 (en) 2001-05-01
CN1347693A (zh) 2002-05-08
EP0759917A1 (en) 1997-03-05
JP4234917B2 (ja) 2009-03-04
JP2006036770A (ja) 2006-02-09
ES2118674T1 (es) 1998-10-01
JPH11501908A (ja) 1999-02-16
CN1185223C (zh) 2005-01-19
HUP9800026A3 (en) 2002-04-29
US20050176758A1 (en) 2005-08-11
JP2002161074A (ja) 2002-06-04
ATE191711T1 (de) 2000-04-15
ATE305453T1 (de) 2005-10-15
US5952375A (en) 1999-09-14
AU720933B2 (en) 2000-06-15
DE10299052I1 (de) 2003-05-22
DE69607704T2 (de) 2000-12-28
CZ297945B6 (cs) 2007-05-02
ES2249863T3 (es) 2006-04-01
CZ269097A3 (en) 1997-11-12
SI9620042A (sl) 1998-12-31
HK1026893A1 (en) 2000-12-29
NL300105I2 (nl) 2003-02-03
CN1147813A (zh) 1997-04-16
ES2118674T3 (es) 2000-08-16
NO973908L (no) 1997-10-27
EP0759917B1 (en) 2000-04-12
NO973908D0 (no) 1997-08-26
MX9706496A (es) 1997-11-29
BR9607098B8 (pt) 2014-11-18
UA56128C2 (uk) 2003-05-15
JP3300365B2 (ja) 2002-07-08
NZ306625A (en) 2001-04-27
SG45864A1 (en) 1999-04-27
NL300105I1 (nl) 2003-01-06

Similar Documents

Publication Publication Date Title
KR100447096B1 (ko) 바이러스성또는세균성뉴라미니다제의신규한선택적저해제
US5763483A (en) Carbocyclic compounds
WO1996026933A9 (en) Novel selective inhibitors of viral or bacterial neuraminidases
KR20010024123A (ko) 6-원 고리를 갖는 화합물, 그의 제조 방법 및의약물로서의 용도
US5866601A (en) Carbocyclic compounds
JP2008273948A (ja) ウイルスまたは細菌ノイラミニダーゼの新規な選択的インヒビター
US20040053999A1 (en) Novel compounds and methods for synthesis and therapy
JP2001502690A (ja) ピペリジン化合物
AU2003204079B2 (en) Novel compounds and methods for synthesis and therapy
HK1120494B (en) Novel compounds and methods for synthesis and therapy
HK1115749A (en) Novel compounds and methods for synthesis and therapy

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 19970826

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20010220

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20030624

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20040628

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20040825

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20040826

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
PR1001 Payment of annual fee

Payment date: 20070821

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 20080821

Start annual number: 5

End annual number: 5

PR1001 Payment of annual fee

Payment date: 20090818

Start annual number: 6

End annual number: 6

PR1001 Payment of annual fee

Payment date: 20100810

Start annual number: 7

End annual number: 7

PR1001 Payment of annual fee

Payment date: 20110810

Start annual number: 8

End annual number: 8

FPAY Annual fee payment

Payment date: 20120807

Year of fee payment: 9

PR1001 Payment of annual fee

Payment date: 20120807

Start annual number: 9

End annual number: 9

FPAY Annual fee payment

Payment date: 20130809

Year of fee payment: 10

PR1001 Payment of annual fee

Payment date: 20130809

Start annual number: 10

End annual number: 10

FPAY Annual fee payment

Payment date: 20140806

Year of fee payment: 11

PR1001 Payment of annual fee

Payment date: 20140806

Start annual number: 11

End annual number: 11

FPAY Annual fee payment

Payment date: 20150806

Year of fee payment: 12

PR1001 Payment of annual fee

Payment date: 20150806

Start annual number: 12

End annual number: 12

EXPY Expiration of term
PC1801 Expiration of term

Termination date: 20160826

Termination category: Expiration of duration